HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 3,889-3,900 of 7,264
Other study type icon
CompletedACTRN12608000255381

Problem solving in people with diabetes and depressive symptoms

Official study title

In people with diabetes and depressive symptoms is problem solving therapy plus self help and a letter to the GP better than self help and a letter to the GP alone in reducing depressive symptoms and improving diabetes management after 6 months.

This study has finished and is no longer accepting participants.

In New Zealand
DepressionInterventional studyAges 16+
Countries
New Zealand
Sponsor
University of Auckland
Behavioral study icon
CompletedACTRN12614000523606

The effects of mindfulness training on maternal stress, depressive symptoms and awareness of present moment experience: A study.

Official study title

In pregnant women, does mindfulness training, compared to pregnancy support, reduce maternal stress and depressive symptoms, and increase awareness of present moment experience?

This study has finished and is no longer accepting participants.

In Berwick
Depression, AnxietyInterventional studyAges 18+
Countries
Australia
Sponsor
Jill Beattie
Behavioral study icon
CompletedACTRN12616000537459

The Target-D Study: An individually controlled study of a clinical prediction tool to triage and target treatment for depressive symptoms in general practice.

Official study title

The Target-D Study: An individually randomised controlled trial of a clinical prediction tool to triage and target treatment for depressive symptoms in general practice.

This study has finished and is no longer accepting participants.

In Australia
DepressionInterventional studyAges 18–65
Countries
Australia
Sponsor
University of Melbourne
Drug study icon
CompletedEUCTR 2005-004006-81

A double-blind, 6 to 12-month, multicenter, multinational, randomized study evaluating the efficacy and safety of SR58611A (350 mg q12) versus placebo in the prevention of relapse / recurrence of d...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic
DepressionHistorical research record
Countries
Czechia, Finland, Slovakia
Sponsor
sanofi-aventis recherche&developpement
Drug study icon
CompletedEUCTR 2014-004393-41

A double-blind, placebo-controlled study of the impact of prophylactic treatment with Galantamine 8mg of cognitive impairment during an electroconvulsive therapy (ECT) in patients with major depre...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
DepressionHistorical research record
Countries
Belgium
Sponsor
CUB Hospital Erasme
Drug study icon
CompletedEUCTR 2016-003990-17

A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Sympto...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
DepressionHistorical research record
Countries
Bulgaria, Germany, Hungary, + 2 others
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedEUCTR 2011-002160-24

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients with Major D...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
DepressionHistorical research record
Countries
Austria, Germany, Slovakia
Sponsor
F. Hoffmann-La Roche Ltd.
Drug study icon
CompletedEUCTR 2005-003745-14

A Multi-centre, Double-blind, Randomised Withdrawal, Parallel-group, Placebo-controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SR®) as Monothe...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Finland
DepressionHistorical research record
Countries
United Kingdom, Finland, Germany, + 1 other
Sponsor
AstraZeneca AB
Drug study icon
CompletedEUCTR 2015-002007-29

A Phase 2a Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-center Study Investigating the Efficacy, Safety, and Tolerability of JNJ-42165279 in Subjects with Major Depressive Di...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Spain
Depression, AnxietyHistorical research record
Countries
United Kingdom, Spain
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedEUCTR 2009-017523-26

A randomised, double-blind, parallel-group, placebo-controlled, duloxetine-referenced, fixed-dose study evaluating the efficacy and safety of Lu AA21004 (15 and 20 mg/day) in the acute treatment of...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
DepressionHistorical research record
Countries
Belgium, Estonia, Finland, + 5 others
Sponsor
H. Lundbeck A/S

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.